Surrozen
Shirley Shi began their work experience in 1999 as a Research Associate at Hyseq Pharmaceuticals Inc., which was later acquired by Nuvelo Inc. and ARCA biopharma Inc. Shirley then moved on to Five Prime Therapeutics, Inc. in 2002, where they worked as a Senior Research Specialist for 17 years until December 2019. Currently, they are an Associate Scientist at Surrozen, starting from January 2020.
Shirley Shi has a Bachelor of Medicine and is a Medical Doctor from the Xiangya School of Medicine at Central South University in China. The specific years of their education are not provided.